All companies › BIVI

BIVI · BIOVIE INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys4
Open-market sells0
Total purchased$49,118
Unique insiders buying4
Most senior buyerCEO
Avg price paid$2.11
Research cases0
Last filing2026-08-28

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-27 — DO CUONG V · bought 15,210 @ $2.08 2026-08-28 — Palumbo Joseph M · bought 4,843 @ $2.16 2026-08-28 — Chappell Amy Suzon · bought 727 @ $2.16 2026-08-28 — KIM JOANNE WENDY · bought 2,500 @ $2.18
2026-08-272026-08-28

Insider cost basis

Share-weighted average price across 4 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$2.08 $2.18
$2.11 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

DO CUONG V President & CEO
Palumbo Joseph M Chief Medical Officer
Chappell Amy Suzon Director
KIM JOANNE WENDY Chief Financial Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $BIVI is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 4 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-08-28', 'insider_name': 'Palumbo Joseph M', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market buy', 'shares': 4843.0, 'price': 2.16, 'value': 10460.88, 'is_buy': True}, {'transaction_date': '2026-08-28', 'insider_name': 'Chappell Amy Suzon', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 727.0, 'price': 2.16, 'value': 1570.32, 'is_buy': True}, {'transaction_date': '2026-08-28', 'insider_name': 'KIM JOANNE WENDY', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market buy', 'shares': 2500.0, 'price': 2.18, 'value': 5450.0, 'is_buy': True}, {'transaction_date': '2026-08-27', 'insider_name': 'DO CUONG V', 'insider_title': 'President & CEO', 'transaction_type': 'Open-market buy', 'shares': 15210.0, 'price': 2.08, 'value': 31636.8, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for BIVI today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.